Medical News Observer

Key points

• The cellular metabolism and depression study analyzed 448 metabolites in 99 patients with treatment-refractory major depressive disorder and suicidal thoughts, revealing lipid abnormalities and altered nucleic acid turnover.
• Findings include sex-specific differences in metabolism, with 75% of metabolic abnormalities unique to individuals, highlighting personalized treatment potential.
• Mitochondrial dysfunction and reductive stress are identified as key factors in suicidal ideation among severe MDD patients, opening new paths for research.

Major depressive disorder (MDD) is a significant health concern in the United States, affecting over 16 million adults and incurring an annual cost of $210 billion. 

Cellular metabolism and depression study

The University of California San Diego School of Medicine researchers conducted a study that establishes a possible link between cellular metabolism and depression. The research revealed that individuals with depression and suicidal thoughts have specific detectable compounds in their blood, which vary based on sex. 

Peripheral blood metabolomics

The study used peripheral blood metabolomics to understand the biology of treatment-refractory Major Depressive Disorder (MDD) with suicidal ideation. It aimed to find individual differences in personalized care. It involved 99 patients with this condition (52 females, 47 males) and 94 age- and sex-matched healthy controls. The study analyzed 448 metabolites. These included key mitochondrial dysfunction biomarkers, FGF21 and GDF15. 

Results

The study results showed a significant metabolic impact from lipid abnormalities, especially in females (75%) compared to males (55%). There was an increase in modified purines and pyrimidines, suggesting altered nucleic acid turnover. Elevated FGF21 levels were found in both sexes. Changes in lactate, glutamate, saccharopine, and cystine levels indicated reductive stress. Interestingly, 75% of metabolic abnormalities were unique to individuals, highlighting the potential for personalized treatments. Deficiencies varied among patients, including in CoQ10, FAD, citrulline, lutein, carnitine, and folate. 

The study identifies possible mitochondrial function’s central role. It shows mitochondrial dysfunction and reductive stress as factors in suicidal ideation among those with treatment-refractory major depressive disorder. These preliminary findings must be interpreted cautiously.

Implications

The study explores the potential of using supplements like folate and carnitine in personalized depression treatment, although they are not considered complete cures. The implications of this newfound understanding for the future of personalized depression treatment are profound, necessitating continued and focused research in this area.

Reference

Pan, Lisa A., Jane C. Naviaux, Lin Wang, Kefeng Li, Jonathan M. Monk, Sai Sachin Lingampelly, Anna Maria Segreti, et al. 2023. “Metabolic Features of Treatment-Refractory Major Depressive Disorder with Suicidal Ideation.” Translational Psychiatry 13 (1): 1–12. https://doi.org/10.1038/s41398-023-02696-9